Details for New Drug Application (NDA): 010220
✉ Email this page to a colleague
NDA 010220 describes HYPAQUE-M,90%, which is a drug marketed by Ge Healthcare and is included in one NDA. Additional details are available on the HYPAQUE-M,90% profile page.
The generic ingredient in HYPAQUE-M,90% is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
The generic ingredient in HYPAQUE-M,90% is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.
Summary for 010220
| Tradename: | HYPAQUE-M,90% |
| Applicant: | Ge Healthcare |
| Ingredient: | diatrizoate meglumine; diatrizoate sodium |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 60%;30% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50%;25% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
